BARR PREPARED TO SATISFY FTC REQUIREMENTS FOR POTENTIAL ACQUISITION OF PLIVA D.D.

Barr Pharmaceuticals, Inc. announced that it is prepared to satisfy any requirements that the U.S. Federal Trade Commission (FTC) might impose regarding the Company's proposed tender offer to purchase 100% of the shares of PLIVA d.d., based in Zagreb, Croatia. Consequently, the company will not include an FTC approval condition in the formal tender offer it intends to file with the Croatian Financial Services Supervisory Agency (HANFA) later this week.
Drug Newswire